From: Development of Corona-virus-disease-19 Vaccines
| Vaccine type | Advantages | Disadvantages | Examples of other vaccines |
|---|---|---|---|
| Virus vector | Easy to develop, theoretically safe | Poor precedent | Ebola, gene therapy |
| Nucleic acids (DNA, mRNA) | Easy to develop, theoretically safe | Poor precedent | None |
| Virus (inactivated or live vaccine) | Most proven | Possibility of antibody-dependent disease enhancement | Measles, rubella, influenza, and many other diseases |
| Recombinant protein | Proven | Adjuvant is often required | Hib, hepatitis B, HPV, pneumococcus, meningococcus |
